Dr. Joseph A. Miccio
Claim this profilePenn State Milton S Hershey Medical Center
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
8 reported clinical trials
25 drugs studied
Affiliated Hospitals
Clinical Trials Joseph A. Miccio is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
More about Joseph A. Miccio
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Joseph A. Miccio has experience with
- Apalutamide
- Degarelix
- Histrelin
- Leuprolide
- Relugolix
- Buserelin
Breakdown of trials Joseph A. Miccio has run
Prostate Adenocarcinoma
Prostate Cancer
Cancer
Adenocarcinoma
Lung Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph A. Miccio specialize in?
Joseph A. Miccio focuses on Prostate Adenocarcinoma and Prostate Cancer. In particular, much of their work with Prostate Adenocarcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Joseph A. Miccio currently recruiting for clinical trials?
Yes, Joseph A. Miccio is currently recruiting for 6 clinical trials in Hershey Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Joseph A. Miccio has studied deeply?
Yes, Joseph A. Miccio has studied treatments such as Apalutamide, Degarelix, Histrelin.
What is the best way to schedule an appointment with Joseph A. Miccio?
Apply for one of the trials that Joseph A. Miccio is conducting.
What is the office address of Joseph A. Miccio?
The office of Joseph A. Miccio is located at: Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania 17033-0850 United States. This is the address for their practice at the Penn State Milton S Hershey Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.